Sanofi CEO Paul Hudson highlights the company's immunology pipeline, emphasizing its global excellence. He discusses how Sanofi's 'Little Moments' are powered by cutting-edge science and partnerships, such as with the Anderson Lab, sparking the future of mRNA research. Hudson also shares insights on fostering a thriving company culture in a distributed hybrid world.